SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS ()
Subject: Drug-resistant staph MRSA VRSA deaths may surpass AIDS toll
Date: October 16, 2007 at 7:24 pm PST

Press Release
For Immediate Release
Tuesday, October 16, 2007
Contact: CDC Media Relations
(404) 639-3286

CDC estimates 94,000 invasive drug-resistant staph infections occurred in the U.S. in 2005
Study establishes baseline for MRSA infection estimates
Methicillin每resistant staph aureus (MRSA) caused more than 94,000 life每threatening infections and nearly 19,000 deaths in the United States in 2005, most of them associated with health care settings, according to the most thorough study of life每threatening infections caused by these bacteria, experts with the Centers for Disease Control and Prevention (CDC) report.

The study in the Oct. 17 edition of the Journal of American Medical Association (JAMA) establishes the first national baseline by which to assess future trends in invasive MRSA infections. MRSA infections can range from mild skin infections to more severe infections of the bloodstream, lungs and at surgical sites.

The study found about 85 percent of all invasive MRSA infections were associated with health care settings, of which two每thirds surfaced in the community among people who were hospitalized, underwent a medical procedure or resided in a long每term care facility within the previous year. In contrast, about 15 percent of reported infections were considered to be community每associated, which means that the infection occurred in people without documented health care risk factors.

The 2005 rates of invasive infection were highest among people 65 years of age or older. Black people were affected at twice the rate of whites, which could be due to higher rates of chronic illness among blacks.

※These numbers show that many families are being affected by these drug每resistant infections,§ said Denise Cardo, M.D., director of CDC∩s Division of Healthcare Quality Promotion. ※Healthcare facilities need to make MRSA prevention a greater priority. The closer we get to 100 percent compliance with CDC recommendations, the greater the impact on patient health and safety.§

Experts arrived at the new national estimate by projecting from the number of invasive MRSA cases from nine U.S. sites. The sites included the state of Connecticut; the Atlanta metropolitan area; the San Francisco Bay area; the Denver metropolitan area; the Portland, Ore., metropolitan area; Monroe County, N.Y.; Baltimore City, Md.; Davidson County, Tenn.; and Ramsey County, Minn. All the sites were part of CDC∩s Active Bacterial Core surveillance program, which actively tracks a number of pathogens in the United States representing a population of 38 million Americans.

In health care settings, MRSA occurs most frequently among patients who undergo invasive medical procedures or who have weakened immune systems and are being treated in hospitals and health care facilities such as nursing homes and dialysis centers.

For more information on MRSA, please visit http://www.cdc.gov/ncidod/diseases/submenus/sub_mrsa.htm. For more information on CDC∩s guidelines for the prevention of MRSA in health care settings, visit http://www.cdc.gov/ncidod/dhqp/ar_mrsa_prevention.html.

###
DEPARTMENT OF HEALTH AND HUMAN SERVICES

Content Source: Office of Enterprise Communication
Page last modified: October 16, 2007


http://www.cdc.gov/od/oc/media/pressrel/2007/r071016.htm

CDC: Drug-resistant staph MRSA VRSA deaths may surpass AIDS toll

http://edition.cnn.com/2007/HEALTH/conditions/10/16/mrsa.cdc.ap/

Lee Memorial attacking infection
New test slated to help fight staph

By Jennifer Booth Reed
jreed@news-press.com
Originally posted on September 18, 2007



Lee Memorial Health System is adding new tools to its infection-fighting arsenal.

The board of directors has given preliminary approval to $286,000 worth of equipment that will be used to screen every intensive care unit patient for the tough-to-fight and increasingly common staph infections plaguing U.S. hospitals. Final approval will come at the board*s meeting this week.

Known as MRSA 〞 methicillin-resistant Staphylococcus aureus 〞 the bug is the No. 1 cause of hospital-acquired infections. As its name implies, it is resistant to many commonly used antibiotics.

MRSA cases are on the rise both in hospitals and in the community. A June study by the Association for Professionals in Infection Control and Epidemiology found 46 of every 1,000 patients surveyed were infected with or were a carrier of MRSA. The rate is between eight and 11 times greater than previous estimates.

MRSA and related bloodstream infections afflict about 350,000 patients a year, and kill 90,000. Recently, the Centers for Medicare and Medicaid Services announced it would no longer pay hospitals to treat infections the agency believes were preventable.

It costs U.S. hospitals $5 billion to $6 billion a year to treat hospital-acquired infections. Lee Memorial lost $2.3 million during this fiscal year on 63 cases.

The new lab equipment will detect MRSA from a patient*s nasal swab in two hours, as opposed to the 48 hours needed with previous testing technology. Knowing a patient*s MRSA status quickly could save the system as much as $278,000 in supplies and $69,806 worth of nursing time.

That*s because patients are kept under isolation until their status is known, and nurses are required to change gowns, masks and gloves every time they come in contact with them.

※We*re trying to stay on the cutting edge,§ said Fran Coleman, the system director of microbiology.

With final approval, the new technology will complement another testing system adopted four months ago.

In May, the system began using a new molecular test developed by the Massachusetts firm AdvanDx that can determine whether patients have staph infections in their bloodstream.

In medical terms, the test is known by the acronym PNA-fish.

The test shaves off one to two days from the time it takes to identify a patient*s infection.

In the past, testing worked like this:

Clinicians drew a patient*s blood and sent it to the system*s central lab at Cape Coral Hospital. There, laboratory technicians could tell fairly quickly whether a patient had an infection. But they didn*t know what kind it was. To learn that, they had to culture the blood for one to two days.

With the new test, once technicians have determined there are bacteria in a patient*s blood, they*ll know within two hours whether the infection is caused by a type of staph.

※We*re providing vital, useful information to a doctor 42 to 72 hours earlier,§ said Philip Onigman, the company*s director.

First to test

Lee Memorial is the first hospital in South Florida to adopt the test and one of 50 major labs nationally to do so, according to AdvanDx.

The rapid test has implications for patients and hospitals, Onigman said.

Doctors generally begin administering antibiotics as soon as they suspect infection. But using the blood culture test, it would be days before they knew whether the patient really needed them.

※Many patients are on a three-, four-day drug regimen when they don*t need it,§ Onigman said.

Translation: Longer hospital stays for patients and higher costs for treatment, not to mention further contributions to the nation*s growing problem of antibiotic overuse.

Bacteria aren*t as prevalent in other parts of the world, Coleman said. In Northern Europe, for example, about 2 percent of the population carries MRSA, Coleman said. In the United States, the rate is 50 to 65 percent.

On the flip side, patients who need treatment can get it sooner, Onigman said.

The traditional blood culture is still done because it gives doctors more specific information about the bug and the kinds of drugs that best will kill it.

※It certainly makes life a little easier when you know a day sooner whether you*re dealing with an infection,§ said Sandy Estrada, a Lee Memorial clinical pharmacist. ※We don*t want them to be on just antibiotic. We want them on the best antibiotic.§

Awaiting data

Lee Memorial doesn*t yet have data on whether the AdvanDx test has improved patient outcomes or saved money.

A study published by the journal Diagnostic Microbiology and Infectious Disease suggested the test saved $1,837 per patient in reducing unnecessary antibiotics. A study by the Washington Hospital Center in Washington, D.C., found mortality rates in the intensive care unit fell 80 percent after switching to the new rapid test.

Estrada said some clinicians were initially skeptical of the new test. But she has found it to be 100 percent accurate when measured against results of the traditional culture.

※When I first heard about it, it seemed too good to be true. We*ve been doing the same thing for years and years and years,§ Estrada said.


http://www.news-press.com/apps/pbcs.dll/article?AID=/20070918/NEWS01/70917049/1075

>>>>MRSA and related bloodstream infections afflict about 350,000 patients a year, and kill 90,000. Recently, the Centers for Medicare and Medicaid Services announced it would no longer pay hospitals to treat infections the agency believes were preventable.<<<<

http://www.news-press.com/apps/pbcs.dll/article?AID=/20070918/NEWS01/70917049/1075


THIS is outrageous. SO, there going to fix the Medicare problem by just letting the old people die that contract MRSA or VRSA in the hospital. no place like the USA. BIG insurance and tort laws, and now Medicare. What's happened to us? I would not be surprised if GW thought of this. He does not want to give the kids health insurance because he chooses to fund Iraq I guess. Now Medicare wants to let the old folks die if they go to the hospital and acquire MRSA or VRSA, just let them die. How much damage can on President do? Now, here is the 600+ billion dollar question, and please think about this very hard. Since it is totally impossible to sue a hospital for MRSA or VRSA acquired infections, due to the lack of science to prove it (to date), even though everyone knows it was a hospital acquired infection after surgery. SO then tell me how in the hell can Medicare refuse to pay for MRSA infections? MRSA damn near killed me in December of 2001 after another neck surgery. After 7+ weeks of vancomycin straight to the heart via pic long-line, I pulled through, with a huge hole in my hip bone, that still hurts to this day. But this really ticks me off, as you can see, and it is just not right for this Adminstration to pull this with Medicare. They better stock up on body bags, because the elderly (for the most part) don't have other insurance. But like I said, this is one way to fix the Medicare problem. I suggest the old folks stay home and don't go to the hospital. I was in one of the finest hospitals in the world too, so don't think it is just in some old run down hospital.

I will not even go into antibiotic resistance issue and the cattle industry and the antibiotics and hormones they pump those cattle up when they are so sick and diseased they cannot even make it to slaughter. but that is a fact, and it is another part of the problem i.e. overuse of antibiotics. If you don't believe me, it's a weekly event, and has been for years, just look at the FDA website, on there weekly warning letters. lets look real quick at this week;


Specifically, you treated the calf bearing tag 904 with 10 cc Duo Pen (Penicillin G Benzathine and Penicillin G Procaine Injectable Suspension) subcutaneously for a navel infection each day between September 18 and 30, 2006. The approved labeling instructions state, "Do not use in calves to be processed for veal." Your veterinarian's protocol instructed you to administer [redacted] to treat ear and navel infections with a [redacted] withdrawal period before slaughter. The sales invoices indicates the calf weighed 176 pounds at the time of sale. Nevertheless, you treated this veal calf at a higher dose and higher frequency than prescribed by your veterinarian, and you shipped this veal calf for slaughter on October 17, 2006 -- only 17 days after the last treatment. You administered this drug contrary to both the approved labeling instructions and those of your veterinarian.

In addition, you adulterated the animal feed that you fed to your veal calves within the meaning of section 501(a)(6) of the Act [21 U.S.C. 351 (a)(6)] by adding NeoMed 325 Soluable Powder (Neomycin Sulfate) and Uniprim Power for Horses (Trimethoprim and Sulfadiazine) to Strauss Veal Feed Market Blend milk replacer. The extralabel use of drugs in or on animal feed is specifically prohibited by section 512(a)(4) [21 USC 360b(a)(4)] of the Act, and 21 CFR Part 530.

The above is not intended to be an all-inclusive list of violations. As a producer of animals offered for use as food, you are responsible for ensuring that your overall operation and the food you distribute is in compliance with the law. You should be aware that your illegal extralabel use of drugs resulted in high levels of drug residues in the edible tissues of veal calves you offered for slaugthter.

http://www.fda.gov/foi/warning_letters/s6534c.htm


On or about September 20, 2006, you sold a dairy cow with Back Tag 9135 for slaughter as food to [redacted]. On or about September 20, 2006, this animal was slaughtered at [redacted] United States Department of Agriculture, Food Safety and Inspection Service (USDA/FSLS) analysis of tissue samples collected from that animal identified the presence of flunixin in the liver at 0.852 parts per million (ppm). A tolerance of 125 parts per billion (or 0.125 ppm) has been established for residues of flunixin in the liver of cattle as codified in Title 21, Code of Federal Regulations, Part 556.286 (21 C.F.R. 556.286). The presence of this amount of this drug in the liver of this animal causes the food to be adulterated within the meaning of section 402(a)(2)(C)(ii) [21 U.S.C. 342(a)(2)(C)(ii)] of the Act.

Our investigation also found that you hold animals under conditions that are so inadequate that medicated animals bearing potentially harmful drug residues are likely to enter the food supply. You lack an adequate system to ensure that animals medicated by you have been withheld from slaughter for appropriate periods of time to permit depletion of potentially hazardous residues of drugs from edible tissues. For example, you failed to maintain adequate treatment records to assure that appropriate withdrawal times have been observed. Food from animals held under such conditions is adulterated within the meaning of section 402(a)(4) [21 U.S.C. 342(a)(4)] of the Act.

In addition,


http://www.fda.gov/foi/warning_letters/s6530c.htm


I think you can get the just from just these two from this week, but these type warning letters are there just about
every week, and have been for years. just go through the archives and see for yourself.


And don't even get me going on mad cow disease in the USA, and the fact we have all been _exposed_, and the fact our federal friends have been conviently covering that up. I know, my mother died from the US version of mad cow disease the Heidenhain Variant of CJD, confirmed. The USA version of mad cow i.e. BASE, is more virulent than the UK BSE. but that's another story. funny, during my surgeries, I bank my own blood when needed, and NEVER used bone grafts due to risk factors of CJD/TSE risk factors and other infectious disease, and what did they do, damn near kill me with MRSA, and then Infectious Disease Team came through the door and the first thing they tried to tell me that everybody has MRSA on there skin. but every nurse I spoke with said it was hospital acquired, and then I found out later that 7 people the week I was in that surgical arena acquired MRSA. Go figure.


SAD, part is, there is no cure for CJD, and it is spreading via the medical, surgical, and dental arena, due to the fact it is very very difficult to kill this agent.
course they will not tell you this either. The USA is going to hell in a handbag, while GW destroys and builds Iraq back. Yep, I am pissed, and have been for years, and I don't care who knows anymore. ...


ABSTRACTS SPORADIC CJD AND H BASE MAD COW ALABAMA AND TEXAS SEPTEMBER 2007

Date: Mon, 24 Sep 2007 21:31:55 -0500

I suggest that you all read the data out about h-BASE and sporadic CJD, GSS,
blood, and some of the other abstracts from the PRION2007. ...

http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0709&L=sanet-mg&T=0&F=&S=&P=19744

*** PLEASE READ AND UNDERSTAND THE RAMIFICATIONS OF THIS !!! THE PRICE OF
POKER INDEED GOES UP. ...TSS

USA BASE CASE, (ATYPICAL BSE), AND OR TSE (whatever they are calling it
today), please note that both the ALABAMA COW, AND THE TEXAS COW, both were
''H-TYPE'', personal communication Detwiler et al Wednesday, August 22, 2007
11:52 PM. ...TSS

http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=19779

CREUTZFELDT JAKOB DISEASE MAD COW BASE, CWD, SCRAPIE UPDATE OCT 2007


http://cjdmadcowbaseoct2007.blogspot.com/

PLEASE NOTE IN USA CJD UPDATE AS AT JUNE 2007, please note steady increase
in ''TYPE UNKNOWN''. ...TSS


1 Acquired in the United Kingdom; 2 Acquired in Saudi Arabia; 3 Includes 17 inconclusive and 9 pending (1 from 2006, 8
from 2007); 4 Includes 17 non-vCJD type unknown (2 from 1996, 2 from 1997, 1 from 2001, 1 from 2003, 4 from 2004, 3
from 2005, 4 from 2006) and 36 type pending (2 from 2005, 8 from 2006, *** 26 from 2007)

http://www.cjdsurveillance.com/pdf/case-table.pdf

still disgusted in Baycliff, Texas USA

Terry S. Singeltary Sr.



Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: